- Faculty
- BR1DGE
Stephan Weidinger
Christian Albrechts University, Kiel, Germany
These are exciting times for immune-mediated diseases with a constantly growing number of innovative therapies across disciplines. This makes education of physicians and patients all the more important to help make the right decisions and improve outcomes
Prof. Stephan Weidinger is currently Professor and Chair for Dermatology at the Christian-Albrechts-University as well as Director of the Department of Dermatology and Allergy at the University Hospital Schleswig-Holstein, Campus Kiel, Germany. In addition to his clinical and research roles, Prof. Weidinger is an Associate Editor of the Journal of Allergy and Clinical Immunology and the British Journal of Dermatology, and Editorial Board member of the Journal of Investigative Dermatology and the Journal of the European Academy of Dermatology and Venereology. His main research interests lie in the molecular mechanisms and treatment of allergic and chronic inflammatory skin diseases, in particular atopic dermatitis, and he has published numerous peer-reviewed publications on this and other related topics. He is coordinator of the international BIOMAP (Biomarkers in Atopic Dermatitis and Psoriasis) consortium funded by the European Union’s Horizon 2020 research and innovation program and EFPIA, is involved in the EU/IMI ImmUniverse project, is principal investigator in the German Excellence Cluster “Precision Medicine in Inflammation”, and of the German atopic dermatitis registry TREATGermany. He is also involved in multiple clinical trials on atopic dermatitis, hand eczema and alopecia areata. Prof. Weidinger has been presented with multiple awards including the Langerhans Award of the German Society for Dermatological Research (ADF), the PhARF (Phadia Allergy Research Forum) Award, the European Centre for Allergy Research Foundation (ECARF) Award, the Allergopharma Award, a Heisenberg fellowship of the German Research Council, and the Herxheimer Award of the German Society for Allergy and Clinical Immunology.